The purpose of this paper was to establish proof of concept for administration of human recombinant F.IX (rF.IX) by inhalation for therapy of hemophilia B. The pharmacokinetics of intratracheal (IT) administration of rF.IX was studied in nine hemophilia B dogs randomized into 3 groups that received 200 IU/kg IT, 1,000 IU/kg IT, or 200 IU/kg intravenously (IV). IT rF.IX produced therapeutic levels of F.IX antigen and activity and the pharmacokinetic parameters were consistent with a slow release from a depot site within the lungs. Bioavailability compared to IV administration was 11% for 200 IU/kg IT and 4.9% for 1,000 IU/kg. The whole blood clotting time began to shorten at 2 h but F.IX bioactivity was not detected until 8 h post infusion in both IT groups. In all groups, F.IX activity was detected through 72 h post administration. These data demonstrate that biologically active rF.IX can reach the systemic circulation when given IT. Aerosolization of rF.IX may provide a needle-free therapeutic option for delivery of rF.IX to hemophilia B patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

200 iu/kg
12
intratracheal administration
8
therapeutic levels
8
hemophilia dogs
8
1000 iu/kg
8
detected post
8
rfix
6
iu/kg
5
administration recombinant
4
recombinant human
4

Similar Publications

Objective: To evaluate the therapeutic dose and safety of bemiparin in neonatal thrombosis treatment.

Study Design: A retrospective review was conducted on infants treated with bemiparin between 2018 and 2023 at a tertiary hospital.

Results: 72 neonates with a mean gestational age of 37 weeks were included.

View Article and Find Full Text PDF

Background: Rabies, a zoonotic disease, poses a significant global public health challenge, and post-exposure prophylaxis (PEP) is crucial for prevention. Monoclonal antibodies (mAbs) have emerged as a promising alternative to rabies immunoglobulins due to their high efficacy and standardized manufacturing process.

Materials And Methods: A prospective, open-label post-marketing surveillance study was conducted with patients of WHO category-III suspected rabid animal bites.

View Article and Find Full Text PDF

This study investigated the individual and combined effects of a high dietary n-3 PUFA intake and cyclic heat stress (HS) on the carcass characteristics, meat quality, and oxidative stability of broiler breast meat and the potential of antioxidant supplementation (vitamins E, C, and selenium) to mitigate these effects. A total of 192 one-day-old male Ross 308 broilers were randomly assigned to 24 pens within two controlled environment chambers and fed with the following diets: a basal diet low in antioxidants according to NRC recommendations (NRC group), a basal diet according to Aviagen recommendations additionally supplemented with 200 IU/kg vitamin E, 250 mg/kg vitamin C, and 0.15 mg/kg selenium (HAOX group), and these two diets further supplemented with 5% linseed oil (NRC N-3 and HAOX N-3 groups).

View Article and Find Full Text PDF

Vitamin D requirements and relative bioavailability for starter male White Pekin ducks fed either cholecalciferol or 25-hydroxycholecalciferol.

Poult Sci

November 2024

State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, 100193, China. Electronic address:

The objectives were to investigate effects of various concentrations of dietary vitamin D (VD) or 25-hydroxycholecalciferol (25-OH-D) on growth performance, VD status, calcium (Ca) metabolism, and tibia mineralization of starter male White Pekin ducks, and dietary requirements and relative bioavailability of these two compounds. One-day-old male White Pekin ducks (n = 624) were assigned to 13 dietary treatments, including 6 added VD concentrations (100, 200, 400, 800, 1200, and 2000 IU/kg), and 2 vitamin D sources (VD and 25-OH-D), plus a negative control (no vitamin D supplementation) for 21 days. Each group had 6 replicate pens of 8 birds per pen.

View Article and Find Full Text PDF
Article Synopsis
  • Delirium is a common and serious symptom in septic patients, linked to higher mortality rates, while acute hyperglycemia (AH) is identified as a risk factor that may worsen delirium outcomes.
  • This study examined the relationship between blood glucose levels and delirium incidence in septic ICU patients, employing a rat model to analyze the effects of different glucose levels on neuroinflammation and cognitive function.
  • Results indicated that AH is an independent risk factor for delirium in sepsis, increasing inflammatory cytokines in the brain and potentially worsening cognitive impairments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!